Open Government Portal
Good Laboratory Practice (GLP) covers the organizational process and the conditions under which non-clinical health and environmental safety studies are …
A non-prescription drug Category IV Monograph outlines the permissible conditions of use and labelling requirements, such as dose, intended use, …
The purpose of this document is to provide guidance to sponsors to facilitate compliance with the labelling requirements pursuant to …
The safe use of non-prescription drugs depends on consumers being able to identify the desired product and also being able …
A nonprescription drug labelling standard outlines the permissible conditions of use and labelling requirements, such as dose, intended use, directions …
Hepatotoxicity caused by exposure to a drug or non-infectious agent is injury or damage to the liver that may be …
Health Canada initiated a Hormone Replacement Therapy (HRT) class labelling project in light of new safety information derived from the …
This proposed guidance will assist manufacturers, packagers, and distributors of non-prescription drugs in developing plain language labelling content for a …
An antiseptic product is considered to be one that inactivates, reduces, prevents or arrests growth of microorganisms with the inherent …
This monograph applies to products in the form of liquid concentrate that are intended to be used for acute and …